[Therapeutic perspectives of cutaneous T-cell lymphoma]

Ann Dermatol Venereol. 2011 May;138(5 Suppl 2):H19-22. doi: 10.1016/S0151-9638(11)70072-2.
[Article in French]
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bexarotene
  • Clinical Trials as Topic
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / therapeutic use
  • Gemcitabine
  • Histone Deacetylase Inhibitors / therapeutic use
  • Humans
  • Interferons / therapeutic use
  • Lymphoma, T-Cell, Cutaneous / pathology
  • Lymphoma, T-Cell, Cutaneous / therapy*
  • Retinoids / therapeutic use
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Tetrahydronaphthalenes / therapeutic use

Substances

  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors
  • Retinoids
  • Tetrahydronaphthalenes
  • Deoxycytidine
  • Interferons
  • Bexarotene
  • Gemcitabine